Tectonic Therapeutic Inc — Financial Statements (NASDAQ:TECX)

Financials

Total revenue ——23 K77 K0153 K — Gross profit ——23 K77 K0153 K — Operating expenses 120.23 M118.84 M105.43 M71.67 M58.02 M84.04 M 84.04 M Selling/general/admin expenses 32.99 M35.73 M33.25 M23.97 M16.65 M20.55 M 20.55 M Research & development 87.24 M83.11 M72.19 M47.7 M41.36 M63.49 M 63.49 M Operating income 120.23 M118.84 M105.43 M10.19 M58.02 M84.04 M 84.04 M Non-Operating Income, Total 516 K285 K456 K2.34 M33 K11.12 M 11.12 M Interest expense, net of interest capitalized ——1.86 M1.94 M107 K63 K 63 K Non-Operating Income, excl. Interest Expenses 719 K346 K-1.25 M485 K-585 K10.93 M 10.93 M Unusual income/expense -203 K-61 K-157 K-78 K511 K119 K 119 K Pretax income 120.74 M119.13 M104.08 M11.56 M57.94 M72.92 M 132.09 M Equity in earnings —————— — Taxes 000377 K01.23 M — Non-controlling/minority interest ———12.53 M—— — After tax other income/expense —————— — Net income before discontinued operations 119.71 M119.13 M105.89 M12.16 M58 M74.15 M 74.16 M Discontinued operations —————— — Net income 119.71 M119.13 M105.89 M12.16 M58 M74.15 M 74.16 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 119.71 M119.13 M105.89 M12.16 M57.98 M74.15 M 74.15 M Basic earnings per share (Basic EPS) ——-2.420.27-6.83-4.05 -4.05 Diluted earnings per share (Diluted EPS) ——-2.420.27-6.83-4.05 -4.05 Average basic shares outstanding ——43.74 K44.33 M8.49 M18.32 M 72.87 M Diluted shares outstanding ——43.74 K44.57 M8.49 M18.32 M 72.87 M EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 1.21 M1.4 M1.44 M617 K1.65 M1.38 M 1.38 M